Adaptive Biotechnologies Corporation
DE ˙ MUN ˙ US00650F1093
12,86 € ↑0,04 (0,27%)
2026-06-02
DEL PRIS
SecurityDE:1HM / Adaptive Biotechnologies Corporation
InstitutionInvesco Ltd.
Latest Disclosed Ownership4,450,066 shares
Latest Disclosed Value $ 61,766,916
Invesco Ltd. reports 43.20% increase in ownership of 1HM / Adaptive Biotechnologies Corporation

On May 12, 2026 - Invesco Ltd. filed a 13F-HR form disclosing ownership of 4,450,066 shares of Adaptive Biotechnologies Corporation (DE:1HM) valued at $49,573,735 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 19, 2026 disclosing 3,107,653 shares of Adaptive Biotechnologies Corporation. This represents a change in shares of 43.20% during the quarter. The current value of the position is $57,205,598 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 4,450,066 1,342,413 43.20 61,767 22.39 0.0012
2026-02-19 2025-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 3,107,653 2,216,595 248.76 50,468 278.60 0.0077
2025-11-13 2025-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 891,058 -17,356 -1.91 13,330 25.96 0.0021
2025-08-13 2025-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 908,414 355,883 64.41 10,583 157.81 0.0018
2025-05-12 2025-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 552,531 378,940 218.29 4,105 294.71 0.0008
2025-02-13 2024-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 173,591 4,985 2.96 1,041 20.51 0.0002
2024-11-12 2024-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 168,606 -3,254 -1.89 863 38.75 0.0002
2024-08-13 2024-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 171,860 -2,696 -1.54 622 11.07 0.0001
2024-05-14 2024-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 174,556 66,015 60.82 560 5.46 0.0001
2024-02-13 2023-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 108,541 1,215 1.13 532 -9.08 0.0001
2023-11-13 2023-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 107,326 -2,860 -2.60 585 -20.97 0.0002
2023-08-11 2023-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 110,186 3,775 3.55 739 -21.30 0.0002
2023-05-12 2023-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 106,411 12,316 13.09 940 30.78 0.0003
2023-02-13 2022-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 94,095 2,380 2.59 719 9.95 0.0002
2022-11-14 2022-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 91,715 -2,780 -2.94 653 -14.53 0.0002
2022-08-15 2022-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 94,495 -51,305 -35.19 764 -62.25 0.0002
2022-05-16 2022-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 145,800 -1,403,282 -90.59 2,024 -95.34 0.0005
2022-02-14 2021-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,549,082 36,538 2.42 43,466 -15.45 0.0105
2021-11-15 2021-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,512,544 -20,090 -1.31 51,411 -17.91 0.0130
2021-08-17 2021-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,532,634 213,167 16.16 62,624 17.89 0.0154
2021-05-17 2021-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,319,467 -204,963 -13.45 53,122 -41.07 0.0142
2021-02-16 2020-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,524,430 254,801 20.07 90,139 45.99 0.0262
2020-11-16 2020-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,269,629 38,792 3.15 61,742 3.69 0.0209
2020-08-14 2020-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 1,230,837 1,006,018 447.48 59,547 853.51 0.0213
2020-05-15 2020-03-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 224,819 -30,549 -11.96 6,245 -18.27 0.0026
2020-02-14 2019-12-31 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 255,368 25,614 11.15 7,641 7.62 0.0024
2019-11-14 2019-09-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 229,754 4,754 2.11 7,100 -34.67 0.0019
2019-08-14 2019-06-30 13F/A-1 ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 225,000 225,000 10,868 0.0028
2019-08-14 2019-06-30 13F ADAPTIVE BIOTECHNOLOGIES COR COM 00650F109 225,000 10,868 0.0026
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.